medigraphic.com
SPANISH

Revista ADM Órgano Oficial de la Asociación Dental Mexicana

ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 5

<< Back Next >>

Rev ADM 2022; 79 (5)

SARS-CoV-2 subvariant omicron BA.4 and BA.5.

Orellana-Centeno JE, Guerrero SRN
Full text How to cite this article 10.35366/107961

DOI

DOI: 10.35366/107961
URL: https://dx.doi.org/10.35366/107961

Language: Spanish
References: 13
Page: 264-266
PDF size: 165.84 Kb.


Key words:

COVID-19, omicron, Mexico.

ABSTRACT

Introduction: on 26 April 2022, in Mexico announced the end of the pandemic and the beginning of the endemic phase, since the criteria for considering this transition had been met. The truth is that the possibility of the appearance of new waves of COVID-19 due to new variants, caused by factors such as mobilisation, lack of vaccination in some age groups and the reduction of preventive measures, have undoubtedly made the end of the pandemic phase a long way off, or at least not in the short term. Undoubtedly, the end of the pandemic phase is still a long way off, or at least not in the short term. The purpose of the study is to present information on the emergence, characteristics and some data on the omicron BA.4 and BA.5 subvariants. Conclusions: despite being in a pandemic to endemic process, the emergence of new waves of COVID-19 variants and subvariants will continue to occur due to the mutational capacity of the virus and therefore the immunity obtained will not be sufficient, a global effort is required from the government and the population to continue with the preventive measures implemented since the beginning of the pandemic.


REFERENCES

  1. Quinta ola de COVID: ¿Cuáles son los síntomas de un contagio con las variantes BA.4 y BA.5? El Financiero. julio 10, 2022. Disponible en: https://www.elfinanciero.com.mx/salud/2022/07/10/quinta-ola-de-covid-cuales-son-los-sintomas-de-un-contagio-con-las-variantes-ba4-y-ba5/

  2. Las cepas covid BA.4 y BA.5 presentan cuatro veces más escape vacunal. Redacción médica. 06 jul 2022. Disponible en: https://www.redaccionmedica.com/secciones/sanidad-hoy/las-cepas-covid-ba-4-y-ba-5-presentan-cuatro-veces-mas-escape-vacunal-1158/

  3. BBC News Mundo. BBC. BA.4 y BA.5: Las subvariantes más contagiosas del COVID que están provocando nuevas olas de la pandemia. 17 junio 2022. Disponible en: https://www.bbc.com/mundo/noticias-61831645/

  4. Callaway E. What the latest omicron subvariants mean for the pandemic. Nature. 2022; 606: 848-849.

  5. Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022; 608 (7923): 593-602. doi: 10.1038/s41586-022-04980-y.

  6. Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022; 185 (14): 2422-2433.e13. doi: 10.1016/j.cell.2022.06.005.

  7. Reynolds CJ, Pade C, Gibbons JM, Otter AD, Lin KM, Muñoz Sandoval D et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science. 2022; 377 (6603): eabq1841. doi: 10.1126/science.abq1841.

  8. Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021; 600 (7887): 21. doi: 10.1038/d41586-021-03552-w.

  9. Dyer O. Covid-19: South Africa's surge in cases deepens alarm over omicron variant. BMJ. 2021; 375: n3013. doi: 10.1136/bmj.n3013.

  10. Daria S, Bhuiyan MA, Islam MR. Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actions. J Med Virol. 2022; 94 (4): 1267-1268. doi: 10.1002/jmv.27503.

  11. Sánchez-Talanquer M, González-Pier E, Sepúlveda J, Abascal-Miguel L, Fieldhouse J, Del Río C et al. La respuesta de México al COVID-19: Estudio de caso. Institute for Global Health Sciences; 2021. Disponible en: https://globalhealthsciences.ucsf.edu/sites/globalhealthsciences.ucsf.edu/files/la_respuesta_de_mexico_al_covid_esp.pdf

  12. Wilson R, Jonke G. The ethics of dentists receiving the COVID-19 vaccine: following the American Dental Association principles of ethics and code of professional conduct. J Am Dent Assoc. 2021; 152 (5): 408-409. doi: 10.1016/j.adaj.2021.02.01.

  13. Orellana-Centeno JE, Guerrero-Sotelo RN. Impacto socioeconómico de la COVID-19 en el escenario mexicano. Acta Odont Col. 2021; 11 (2): 127-135. doi: 10.15446/aoc.v11n2.97196.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev ADM. 2022;79